CORE
🇺🇦
make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantation in Primary Amyloidosis
Author
Abounader Donna
Andresen Steven
+14 more
Bolwell Brian
Duong Hien K.
Gerds Aaron
Hamilton Betty
Hanna Rabi
Jagadeesh Deepa
Kalaycio Matt E.
Majhail Navneet S.
Pohlman Brad
Reu Fred
Rybicki Lisa
Samaras Christy
Sobecks Ronald
Valent Jason
Publication venue
Published by Elsevier Inc.
Publication date
28/02/2015
Field of study
Get PDF
Elsevier - Publisher Connector
Low-Dose Lenalidomide after Non-Myeloablative Allogeneic Hematopoietic Cell Transplant with Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma
Author
Aaron T. Gerds
Betty K. Hamilton
+12 more
Brad Pohlman
Brian Bolwell
Brian T. Hill
Deepa Jagadeesh
Donna Corrigan
Fred Reu
Hien Liu
Jack Khouri
Matt E. Kalaycio
Navneet S. Majhail
Robert M. Dean
Ronald M. Sobecks
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Bortezomib-Based Induction Therapy PRIOR to High Dose Melphalan and Autologous Hematopoietic CELL Transplantation in Primary Amyloidosis
Author
Aaron Gerds
Betty Hamilton
+14 more
Brad Pohlman
Brian Bolwell
Christy Samaras
Deepa Jagadeesh
Donna Abounader
Fred Reu
Hien K. Duong
Jason Valent
Lisa Rybicki
Matt E. Kalaycio
Navneet S. Majhail
Rabi Hanna
Ronald Sobecks
Steven Andresen
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Get PDF
Get PDF